CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues	$ 2,768.8	$ 2,881.7	$ 5,592.6	$ 5,672.9
Cost of Revenue	2,008.3	2,056.9	4,104.1	4,058.4
Gross Profit	760.5	824.8	1,488.5	1,614.5
Selling, general and administrative expenses	396.3	415.3	791.8	809.1
Amortization of intangibles and other assets	60.1	60.2	122.4	117.3
Asset Impairment Charges	0.0	0.0	437.4	0.0
Net restructuring and other special charges	6.4	13.6	31.8	34.2
Operating Income (Loss)	297.7	335.7	105.1	653.9
Other income (expenses):
Interest expense	(52.7)	(59.1)	(107.7)	(115.8)
Equity method income, net	1.8	2.5	(4.8)	5.5
Investment income	2.5	1.4	5.1	2.0
Other, net	47.7	(10.5)	31.6	(20.9)
Earnings before income taxes	297.0	270.0	29.3	524.7
Provision for income taxes	65.4	79.3	114.6	148.1
Net earnings	231.6	190.7	(85.3)	376.6
Less: Net earnings attributable to the noncontrolling interest	0.0	(0.3)	(0.3)	(0.6)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 231.6	$ 190.4	$ (85.6)	$ 376.0
Basic earnings per common share (in dollars per share)	$ 2.38	$ 1.94	$ (0.88)	$ 3.82
Diluted earnings per common share (in dollars per share)	$ 2.37	$ 1.93	$ (0.88)	$ 3.79